Expert Ratings For Envista Holdings
Envista Holdings (NYSE:NVST) has observed the following analyst ratings within the last quarter:
Morgan Stanley Maintains Overweight on Envista Holdings, Raises Price Target to $56
Morgan Stanley analyst Drew Ranieri maintains Envista Holdings (NYSE:NVST) with a Overweight and raises the price target from $52 to $56.
Morgan Stanley Maintains Overweight on Envista Holdings, Raises Price Target to $52
Morgan Stanley analyst Drew Ranieri maintains Envista Holdings (NYSE:NVST) with a Overweight and raises the price target from $48 to $52.
Envista Holdings: Q4 Earnings Insights
Envista Holdings (NYSE:NVST) reported its Q4 earnings results on Wednesday, February 9, 2022 at 04:00 PM.
Here's what investors need to know about the announcement.
Envista Holdings Q4 EPS $0.46 Beats $0.41 Estimate, Sales $651.80M Beat $634.83M Estimate
Envista Holdings (NYSE:NVST) reported quarterly earnings of $0.46 per share which beat the analyst consensus estimate of $0.41 by 12.2 percent. This is a 17.86 percent decrease over earnings of $0.56 per share from the
Earnings Scheduled For February 9, 2022
Companies Reporting Before The Bell
• Equinor (NYSE:EQNR) is projected to report quarterly earnings at $0.63 per share on revenue of $25.05 billion.
Envista Holdings Reports Renewal Of Commercial Partnership With Vitaldent Group, No Terms Disclosed
Envista Holdings Corporation (NYSE:NVST) announced that it has renewed its partnership agreement with the Vitaldent Group, a leading Spanish Dental Service Organization (DSO). Vitaldent is dedicated to
Morgan Stanley Upgrades Envista Holdings to Overweight, Announces $48 Price Target
Morgan Stanley analyst Drew Ranieri upgrades Envista Holdings (NYSE:NVST) from Equal-Weight to Overweight and announces $48 price target.
Nobel Biocare Receives FDA 510(k) Clearance For The Nobel Biocare N1 Implant System
Envista Holdings Corporation (NYSE:NVST) ("Envista") today announced that the U.S. Food and Drug Administration (FDA) has cleared the Nobel Biocare N1™ implant system. Boasting a biologically driven